KIDS Stock Overview
A medical device company, engages in designing, developing, and marketing anatomically appropriate implants, instruments, and specialized braces for children with orthopedic conditions in the United States and internationally.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 1/6 |
| Past Performance | 0/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
OrthoPediatrics Corp. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$28.28 |
| 52 Week High | US$40.22 |
| 52 Week Low | US$23.10 |
| Beta | 1.19 |
| 11 Month Change | -12.26% |
| 3 Month Change | -9.04% |
| 1 Year Change | -26.45% |
| 33 Year Change | -56.14% |
| 5 Year Change | -8.89% |
| Change since IPO | 47.14% |
Recent News & Updates
The OrthoPediatrics Corp. (NASDAQ:KIDS) Second-Quarter Results Are Out And Analysts Have Published New Forecasts
Aug 09
Shareholders Should Be Pleased With OrthoPediatrics Corp.'s (NASDAQ:KIDS) Price
Aug 02OrthoPediatrics Corp. (NASDAQ:KIDS) Just Reported And Analysts Have Been Lifting Their Price Targets
May 09Recent updates
The OrthoPediatrics Corp. (NASDAQ:KIDS) Second-Quarter Results Are Out And Analysts Have Published New Forecasts
Aug 09Shareholders Should Be Pleased With OrthoPediatrics Corp.'s (NASDAQ:KIDS) Price
Aug 02OrthoPediatrics Corp. (NASDAQ:KIDS) Just Reported And Analysts Have Been Lifting Their Price Targets
May 09OrthoPediatrics (NASDAQ:KIDS) Has Debt But No Earnings; Should You Worry?
May 07Why Investors Shouldn't Be Surprised By OrthoPediatrics Corp.'s (NASDAQ:KIDS) P/S
Apr 10Why Investors Shouldn't Be Surprised By OrthoPediatrics Corp.'s (NASDAQ:KIDS) P/S
Dec 20Getting In Cheap On OrthoPediatrics Corp. (NASDAQ:KIDS) Might Be Difficult
May 05OrthoPediatrics' (NASDAQ:KIDS) Earnings Aren't As Good As They Appear
Nov 08OrthoPediatrics announces public offering of stock, pre-funded warrants
Aug 10Is OrthoPediatrics (NASDAQ:KIDS) Using Debt In A Risky Way?
Aug 08OrthoPediatrics enters distribution agreement with 3D-Side
Jul 13Shareholder Returns
| KIDS | US Medical Equipment | US Market | |
|---|---|---|---|
| 7D | -7.4% | 0.3% | -2.3% |
| 1Y | -26.4% | 4.4% | 16.7% |
Return vs Industry: KIDS underperformed the US Medical Equipment industry which returned 1.8% over the past year.
Return vs Market: KIDS underperformed the US Market which returned 14.1% over the past year.
Price Volatility
| KIDS volatility | |
|---|---|
| KIDS Average Weekly Movement | 6.6% |
| Medical Equipment Industry Average Movement | 8.4% |
| Market Average Movement | 6.2% |
| 10% most volatile stocks in US Market | 14.6% |
| 10% least volatile stocks in US Market | 3.2% |
Stable Share Price: KIDS's share price has been volatile over the past 3 months.
Volatility Over Time: KIDS's weekly volatility (7%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2006 | 247 | David Bailey | www.orthopediatrics.com |
OrthoPediatrics Corp., a medical device company, engages in designing, developing, and marketing anatomically appropriate implants, instruments, and specialized braces for children with orthopedic conditions in the United States and internationally. The company offers pediatric trauma and deformity correction products; scoliosis procedures for the treatment of spinal deformity; and sports medicine and other products. Its products comprise PediLoc, PediPlates, cannulated screws, PediFlex nail, PediNail, PediLoc Tibia, ACL Reconstruction System, Locking Cannulated Blade, Locking Proximal Femur, Spica Tables, RESPONSE Spine, BandLoc, Pediguard, Pediatric Nailing Platform | Femur, Devise Rail, Orthex, The Fassier-Duval Telescopic Intramedullary System, SLIMTM Nail, The GAP Nail, The Free Gliding SCFE Screw System, GIROTM Growth Modulation System, PNP Tibia System, ApiFix Mid-C System, and Mitchell Ponseti.
OrthoPediatrics Corp. Fundamentals Summary
| KIDS fundamental statistics | |
|---|---|
| Market cap | US$656.45m |
| Earnings (TTM) | -US$25.12m |
| Revenue (TTM) | US$175.07m |
3.9x
P/S Ratio-27.3x
P/E RatioIs KIDS overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| KIDS income statement (TTM) | |
|---|---|
| Revenue | US$175.07m |
| Cost of Revenue | US$44.43m |
| Gross Profit | US$130.64m |
| Other Expenses | US$155.76m |
| Earnings | -US$25.12m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -1.04 |
| Gross Margin | 74.62% |
| Net Profit Margin | -14.35% |
| Debt/Equity Ratio | 2.7% |
How did KIDS perform over the long term?
See historical performance and comparison